OAB were EQUC positive more often than ASF with an OR of 3.9 (95% CI 1.6-9.5, p ¼ 0.003). OAB patients showed mixed microbial composition in 23.6% (13/55) of CUS, while BPH/LUTS patients were all dominated by a single genus (p ¼ 0.003). Lactobacillus dominated in 21.6% (35/162) of women, but was absent in men (p < 0.001).
INTRODUCTION AND OBJECTIVES: DU is a contraction of reduced strength and/or duration, resulting in prolonged or incomplete bladder emptying. Estimates suggest that DU prevalence ranges from 9-23% in men <50 y, but exceeds 48% in men >70y. DU is therefore expected to be a common complication of BOO. Here, we test the hypothesis that DU occurring after BOO results from an early impairment of the bladder afferent signalling mechanism.
METHODS: BOO was obtained by creating partial urethral obstruction in female rats. After 3 and 15 days, rats were anaesthetised and cystometries were performed using saline infusion for 30 minutes at 6 ml/hour. DU and elevated voiding contractions (contr) were defined as the average contr of naïve animals AE 4 sd. This defined the cut-off as <0.2 contr/min and >1 contr/min, respectively. Saline voided was stored for ATP measurement DU bladders were then submitted to (i) intravesical infusion of 5 mg/kg ATP and (ii) serosal application of Ach (1 mM) or ATP 5 mg/kg. Sham-operated animals were used as controls. ATP was measured by bioluminescence using firefly luciferase at 37 C. RESULTS: Control rats had 0.6AE0.1 voiding cont/min. At 3 days after BOO, 63% (5/8) of rats had 1.4AE0.4 contr/min, p<0.01) while 29% (2/8) had normal frequency (0.7AE0.1 voiding contr/min) and 13% (1/8) had DU (0.0AE0.0 voiding contr/min, voiding by overflow). At 15 days, 67% (6/9) of rats had DU (0.1AE0.1 voiding contr/min, p<0.01, most of urine voided by overflow), while the remaining 33% (3/9) had more voiding contractions than controls (1.2AE0.3 cont/min, p<0.05). ATP in saline voided was 1.08E-14 mol/ml in control rats. ATP was significantly higher (1.08E-12 mol ATP/ml, p<0.01) in rats with more voiding contractions and was significantly lower (4.18E-17 mol ATP/ml, p<0.001) in rats with DU.In DU bladders, serosal application of Ach or ATP generated immediate expulsive detrusor contractions (12 cmH20 and 17 cmH20, respectively), indicating the integrity of the detrusor muscle. Intravesical application of ATP generated immediate expulsive detrusor contractions of 46 cmH20, denoting a low availability of urothelial ATP.
CONCLUSIONS: This study suggests that BOO impairs the afferent pathway before impairing the detrusor, with urothelial ATP being less available to promote bladder contraction. This mechanism may open new therapeutic options to overcome DU after BOO.
Source of Funding: None

PD19-05 THERAPEUTIC EFFECTS OF PDE9 INHIBITOR IN STORAGE AND VOIDING DYSFUNCTION IN MICE WITH SPINAL CORD INJURY (SCI)
Nobutaka Shimizu*, Osaka-Sayama, Japan; Ei-ichiro Takaoka, Takahisa Suzuki, Joonbeom Kwon, Pittsburgh, PA; Mamoru Hashimoto, Hirotsugu Uemura, Osaka-Sayama, Japan; Akihide Hirayama, Ikoma, Japan; Anthony J Kanai, William C de Groat, Naoki Yoshimura, Pittsburgh, PA INTRODUCTION AND OBJECTIVES: Phosphodiesterase (PDE) inhibitors, which can modulate cGMP or cAMP levels in tissues, such as PDE type 5 inhibitors have been used for the treatment of lower urinary tract dysfunction (LUTD). However, it remains to be elucidated whether PDE type 9 (PDE9) is involved in LUTD induced by SCI. Therefore, we investigated the effects of a PDE9 inhibitor (PDE9i) to clarify the role of PDE9 in storage and voiding dysfunction using SCI mice.
METHODS: C57BL/6N mice were used, and SCI was induced by complete transection of the Th8/9 spinal cord. Two weeks after SCI, PDE9i (5 mg/kg/day) or saline (treatment or control group, respectively) was administered daily by i.p. injection for 14days in. Four weeks after SCI, mice were evaluated using cystometry (CMG) under an awake condition. L6 dorsal root ganglia (DRG), urethral, bladder muscle and mucosal specimens were obtained from PDE9i and salinetreated SCI mice as well as saline-treated normal (spinal intact) mice to evaluate the levels of PDE9, TRPV1 and TNFa transcripts by realtime PCR RESULTS: Compared to saline-treated SCI mice, non-voiding contractions during bladder filling were significantly reduced (Figure 1) , and voiding efficiency was significantly improved in PDE9i-treated SCI mice (Figure 2 ). The levels of TRPV1 mRNA in DRG and bladder muscle were increased in SCI mice compared to spinal intact mice, and significantly decreased after PDE9i treatment in SCI mice. The TNFa mRNA levels in urethra, bladder muscle and mucosa were increased in SCI mice compared to spinal intact mice, and significantly decreased after PDE9i treatment in SCI mice. PDE9 transcripts were identified in L6 DRG and bladder tissues.
CONCLUSIONS: PDE9 inhibition improved SCI-induced detrusor overactivity and inefficient voiding, along with significant reductions in C-fiber afferent receptors such as TRPV1 and proinflammatory cytokines such as TNFa in mice. Thus, PDE9 could be a therapeutic target for storage and voiding LUTD after SCI. INTRODUCTION AND OBJECTIVES: Nitric oxide (NO) signaling pathway plays an important role in lower urinary tract, principally in the penis. Additionally, NO may contribute to the regulation of urethral and bladder smooth muscle tone. Sickle cell (SC) mouse model exhibit overactive bladder symptoms, but the mechanisms are not understood. We hypothesize that NO dysregulation causes overactive bladder, while NO-releasing nanoparticles (NO-NP), a novel NO delivery system, decreases detrusor overactivity, using eNOS-and nNOSdeficient (dNOS-/-) knockout and SC mice.
METHODS: SC (n¼18) and dNOS-/-knockout (n¼22) mice were used as animal models of overactive bladder and compared to wild type (WT) (n¼15) mice. Empty-NP or NO-NP were injected into the bladder. After 10 minutes, cystometric studies were performed. For molecular studies, bladder tissues were collected from separate groups of mice; the expression levels of proteins that regulate detrusor relaxation (nitric oxide synthase pathway) or contraction (RhoA/Rho-kinase pathway) were assessed. For statistical analysis, the Student's t-test and one-way analysis of variance (ANOVA) were used.
RESULTS: SC and dNOS-/-mice had significantly higher (P < 0.05) voiding and non-voiding contraction frequencies and significantly lower (P < 0.05) compliance compared to WT mice. NO-releasing nanoparticles normalized these abnormalities in both SC and dNOS-/-mice. RhoA/Rho-kinase pathway, reflected by phosphorylation of myosin phosphatase target subunit 1 (P-MYPT-1), was increased (P < 0.05) in the bladder of SC mice compared to WT, which was reversed by NO-releasing nanoparticles. eNOS phosphorylation on positive (Ser-1177) regulatory site was decreased (P < 0.05) in the bladder of SC mice compared to WT, which was reversed by NO-releasing nanoparticles. nNOS phosphorylation on Ser-1412 and VASP phosphorylation on Ser-239 (a substrate of protein kinase G-I and a marker of the integrity of the NO/cGMP signaling pathway) were not different between SC and WT mouse bladders. Empty-NP did not affect any of the measured parameters.
CONCLUSIONS: Dysregulation of NO and RhoA/Rho-kinase pathways is associated with detrusor overactivity in SC mice; NOreleasing nanoparticles reverse these molecular derangements in the bladder and decrease detrusor overactivity.
Source of Funding: This study was supported by a grant from the National Health Institute (R01DK067223).
PD19-07 CRH NEURONS OF BARRINGTON'S NUCLEUS ARE NECESSARY BUT NOT SUFFICIENT FOR CO-ORDINATED VOIDING IN MICE
Hiroki Ito*, Marcus Drake, Christopher Fry, Bristol, United Kingdom; Anthony Kanai, Pittsburgh, PA; Anthony Pickering, Bristol, United Kingdom INTRODUCTION AND OBJECTIVES: The pontine micturition centre (PMC) is thought to activate the sacral parasympathetic neurons controlling the detrusor and inhibit the somatic motoneurons of the external urethral sphincter (EUS). Many PMC neurons express corticotropin-releasing hormone (CRH) and a recent study using CRH-ires-CRE knock-in mice enabled opto-and chemo-genetic manipulation of their activity (Hou et al. Cell 2016) . This indicated that the CRH neurons Vol. 199, No. 4S, Supplement, Saturday, May 19, 2018 THE JOURNAL OF UROLOGY â e397
